| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 … O Miotto, R Amato, EA Ashley, B MacInnis, J Almagro-Garcia, ... Nat Genet, 2015 | 8 | 2015 |
| 19 Antimalarial Agents EA Ashley, NJ White in Theory and Clinical Practice, 379, 2007 | 1 | 2007 |
| A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell’s viper antivenom in Myanmar JA Watson, T Lamb, J Holmes, DA Warrell, KT Thwin, ZL Aung, MZ Oo, ... PLoS Neglected Tropical Diseases 14 (11), e0008109, 2020 | 4 | 2020 |
| A case-control auditory evaluation of patients treated with artemether-lumefantrine R Hutagalung, H Htoo, PAW Nwee, J Arunkamomkiri, J Zwang, VI Carrara, ... American Journal of Tropical Medicine and Hygiene 74 (2), 211-214, 2006 | 73 | 2006 |
| A case–control study of the causes of acute respiratory infection among hospitalized patients in Northeastern Laos K Phommasone, X Xaiyaphet, JA Garcia-Rivera, RD Hontz, ... Scientific Reports 12 (1), 939, 2022 | 10 | 2022 |
| A cautionary note on the use of unsupervised machine learning algorithms to characterise malaria parasite population structure from genetic distance matrices JA Watson, AR Taylor, EA Ashley, A Dondorp, CO Buckee, NJ White, ... PLoS genetics 16 (10), e1009037, 2020 | 3 | 2020 |
| A Clinically Oriented antimicrobial Resistance surveillance Network (ACORN): pilot implementation in three countries in Southeast Asia, 2019-2020 HR van Doorn, T Miliya, A Douangnouvong, NTT Dieu, C Soputhy, M Lem, ... Wellcome open research 7, 2022 | 3 | 2022 |
| A major genome region underlying artemisinin resistance in malaria IH Cheeseman, BA Miller, S Nair, S Nkhoma, A Tan, JC Tan, S Al Saai, ... science 336 (6077), 79-82, 2012 | 472 | 2012 |
| A multi-centre randomised controlled non-inferiority trial to compare the efficacy, safety and tolerability of Triple Artemisinin-based Combination Therapies versus first-line … C Amaratunga, M Dhorda, AM Dondorp, NJ White, NPJ Day, MJ Dhorda, ... | | |
| A multi-country analysis of COVID-19 hospitalizations by vaccination status BP Gonçalves, W Jassat, J Baruch, M Hashmi, A Rojek, A Dasgupta, ... Med 4 (11), 797-812. e2, 2023 | 1 | 2023 |
| A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants L Vachot-Ganée, N Khim, A Iannello, E Legrand, S Kim, R Eam, C Khean, ... Malaria journal 17, 1-12, 2018 | 7 | 2018 |
| A Phase 4 randomised study to assess the tolerability of artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) fixed dose combinations (FDCs) for the treatment of … B Schramm, P Valeh, E Baudin, C Mazinda, R Smith, L Pinoges, ... | 1 | 2010 |
| A pilot study to investigate the risk of SARS-CoV-2 household transmission following hospital discharge of confirmed cases in Vientiane Capital, Lao PDR M Mayxay, P Paboriboune, X Xaiyaphet, K Kunlaya, M Vongsouvath, ... Valasan kanphaet Lao 12, 67, 2021 | | 2021 |
| A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy R McGready, SO Tan, EA Ashley, M Pimanpanarak, J Viladpai-Nguen, ... PLoS medicine 5 (12), e253, 2008 | 167 | 2008 |
| A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy R McGready, EA Ashley, E Moo, T Cho, M Barends, R Hutagalung, ... The Journal of infectious diseases 192 (5), 846-853, 2005 | 125 | 2005 |
| A randomized open study to assess the efficacy and tolerability of dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia B Janssens, M Van Herp, L Goubert, S Chan, S Uong, S Nong, D Socheat, ... Tropical Medicine & International Health 12 (2), 251-259, 2007 | 77 | 2007 |
| A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the … R Hutagalung, L Paiphun, EA Ashley, R McGready, A Brockman, ... Malaria journal 4, 1-6, 2005 | 106 | 2005 |
| A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria EA Ashley, R McGready, R Hutagalung, L Phaiphun, T Slight, S Proux, ... Clinical Infectious Diseases 41 (4), 425-432, 2005 | 157 | 2005 |
| A small amount of fat does not affect piperaquine exposure in patients with malaria A Annerberg, KM Lwin, N Lindegardh, S Khrutsawadchai, E Ashley, ... Antimicrobial agents and chemotherapy 55 (9), 3971-3976, 2011 | 33 | 2011 |
| A Systematic Review of Antimicrobial Resistance Among Children in Low-and Middle-Income Countries in the Western Pacific Region (WPRO) N Moore, EA Ashley, B Dickson, A Douangnouvong, P Panyaviseth, ... Available at SSRN 4430748, 0 | 1 | |
Nicholas WhiteProfessor of Tropical Medicine, Mahidol and Oxford Universities在 tropmedres.ac 的电子邮件经过验证
